OrbiMed’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-177,113
Closed -$551K 179
2021
Q3
$551K Buy
+177,113
New +$551K 0.01% 166